First Tracks Biotherapeutics Acquisition | Healthcare Deal in CA

AnaptysBio, Inc. has divested First Tracks Biotherapeutics, a healthcare services other business in California, for $0.001. First Tracks Biotherapeutics operates in healthcare services other, supporting activities tied to biotherapeutics and related healthcare services in CA. The divestiture acquisition is part of healthcare M&A involving CA acquisitions and healthcare deals CA. The separation and distribution framework includes asset transfers, contract handling, and indemnification provisions, with no binding agreement in the draft form and an announced status pending execution by all parties.